These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 26788570)

  • 1. Optimal HCV combination therapy?].
    Prescrire Int; 2015 Dec; 24(166):288. PubMed ID: 26788570
    [No Abstract]   [Full Text] [Related]  

  • 2. [New combination attains a response rate of 90].
    Warpakowski A
    MMW Fortschr Med; 2015 Sep; 157(15):71. PubMed ID: 26349741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy].
    Iino S
    Rinsho Byori; 2001 Aug; 49(8):747-54. PubMed ID: 11573281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telaprevir for chronic HCV infection.
    van der Meer AJ; de Knegt RJ
    N Engl J Med; 2009 Jul; 361(5):533-4; author reply 534-5. PubMed ID: 19641215
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of measuring HCV-RNA levels in patients with chronic hepatitis C by IFN treatment, including combination therapy with ribavirin].
    Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):507-10. PubMed ID: 15359851
    [No Abstract]   [Full Text] [Related]  

  • 6. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculous sepsis during antiviral HCV triple therapy.
    Hametner S; Monticelli F; Kern JM; Schöfl R; Ziachehabi A; Maieron A
    J Hepatol; 2013 Sep; 59(3):637-8. PubMed ID: 23669285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic and therapeutic difficulties in management of patients with autoimmune hepatitis and HCV coinfection--case reports].
    Woźniak M; Woynarowski M; Socha J
    Przegl Epidemiol; 2005; 59(2):601-4. PubMed ID: 16190572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concomitant nodular goiter during IFN and ribavirin treatment of HCV: a case report].
    Lin F; Wang HF
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):163, 166. PubMed ID: 16700133
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV/HCV coinfection. A good chance of recovery also for dually infected patients].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():7. PubMed ID: 25026843
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents.
    Poordad F; Dieterich D
    J Viral Hepat; 2012 Jul; 19(7):449-64. PubMed ID: 22676357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualisation of antiviral therapy for chronic hepatitis C.
    Teoh NC; Farrell GC; Chan HL
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1206-16. PubMed ID: 20594246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies.
    Zanini B; Covolo L; Donato F; Lanzini A
    Clin Ther; 2010 Dec; 32(13):2139-59. PubMed ID: 21316533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?
    Lagging M; Alsiö S; Hellstrand K; Norkrans G;
    J Hepatol; 2011 Apr; 54(4):835-6; author reply 836-7. PubMed ID: 21145838
    [No Abstract]   [Full Text] [Related]  

  • 15. Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C.
    Aghemo A; De Francesco R
    Gut; 2015 Jun; 64(6):860-2. PubMed ID: 25193803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists].
    Hofmann WP; Bock H; Weber C; Tacke W; Pfaff R; Kihn R; Moog G; Kellner HU; Schöfer M; Frick B; Berg P; Rambow A; Friedrich-Rust M; Herrmann E; Sarrazin C; Zeuzem S
    Z Gastroenterol; 2006 Jan; 44(1):25-31. PubMed ID: 16397836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to the treatment-naïve patient with HCV genotype 1 infection.
    Muir AJ
    Infect Dis Clin North Am; 2012 Dec; 26(4):893-901. PubMed ID: 23083822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic hepatitis C in HIV-infected patients. Unfavorable interaction of HIV and HCV infection].
    Mauss S
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():60-2. PubMed ID: 10863316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of chronic hepatitis C.
    Lo Re V; Kostman JR
    Postgrad Med J; 2005 Jun; 81(956):376-82. PubMed ID: 15937203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic viral hepatitis B and C. Hysteria and panic are no longer appropriate].
    Schwerdtfeger M; Fleig WE
    MMW Fortschr Med; 2000 Nov; 142(46):39-42. PubMed ID: 11132310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.